ULK1 and cancer: A growing number of ULK1 inhibitors have been researched and reported to suppress tumor growth and metastasis and promote autophagy in various cancer types, such as 3s158, SBI-0206965160, WP1130161, ULK-100162, ULK-101162, MRT67307163, MRT68921163, compound 3g164, and compound 6165.